Skip to main content

Table 2 Baseline characteristics in Intervention vs. Control group and divided into Hypertension grades

From: Reduction of cardiovascular risk factors among young men with hypertension using an interactive decision aid: cluster-randomized control trial

 

Hypertension grade 1

Hypertension grade 2

Intervention group (n = 40)

Control group (n = 27)

p value

Intervention group (n = 35)

Control group (n = 24)

p value

Age (y)

40.15 (7.88)

35.52 (8.4)

0.025*

41.89 (6.61)

38.29 (7.55)

0.058

Duration of hypertension (y)†

10.83 (7.45)

9.58 (8.21)

0.525

10.86 (5.64)

10.5 (4.85)

0.801

Systolic blood pressure (mmHg)

135.37 (11.64)

142.11 (16.12)

0.051

140.77 (10.6)

135.42 (14.32)

0.104

Diastolic blood pressure (mmHg)

87.1 (6.93)

85.19 (9.78)

0.351

91.57 (10.23)

88.08 (10.12)

0.202

BMI (kg/m2)

30.08 (3.9)

27.7 (4.23)

0.021*

32.84 (6.43)

32.2 (5.9)

0.7

Waist (cm)

104.1 (11.34)

97.5 (12.62)

0.029*

110.5 (15.96)

108.6 (14)

0.639

Hypertension related medications used (total number)†††

1.31 (0.61)

1.63 (1.04)

0.12

1.71 (0.93)

1.5 (0.83)

0.367

Smokers, n (%)

9 (23)

10 (37)

0.27

12 (34)

9 (38)

1.000

E-Cigarette users, n (%)

0 (0)

0 (0)

1.000

1 (3)

2 (8)

0.561

Cigarettes per day (total number)††

15.78 (4.381)

17.4 (9.06)

0.210

17.67 (8.94)

15.22 (4.52)

0.887

Family anamnesis with infarction/stroke, n (%)

22 (55)

19 (70)

0.307

22 (63)

18 (75)

0.402

Microalbuminuria diagnosis, n (%)†††

2 (5)

1 (4)

1.000

2 (6)

1 (4)

1.000

Laboratory parameters

Total cholesterol (mmol/L)†††

5.79 (1.02)

5.2 (0.9)

0.017*

5.69 (1.14)

5.48 (1.01)

0.463

High-density lipoprotein (mmol/L)†††

1.23 (0.29)

1.41 (0.54)

0.084

1.33 (0.45)

1.19 (0.32)

0.196

Low-density lipoprotein (mmol/L)§

3.71 (0.86)

3.16 (0.79)

0.012*

3.59 (1.33)

3.63 (0.99)

0.916

Triglycerides (mmol/L)†††

2 (1.46)

1.56 (0.92)

0.174

1.88 (1.06)

2.02 (1.18)

0.638

Blood glucose level (mmol/L)§§

5.48 (0.67)

5.22 (1.29)

0.298

5.52 (0.46)

5.28 (0.69)

0.117

eGFR (mL/min/1.73m2)†††

97.04 (14.09)

102.49 (12.43)

0.110

102.75 (18.62)

104.6 (15.24)

0.689

Serum creatinine (mg/dL)†††

80.26 (9.99)

77.86 (8.19)

0.306

76.86 (11)

76.25 (9.88)

0.829

Cardiovascular disease risk scores

10-year stroke or heart attack risk from decision aid(percentage)

9.59 (9.04)

9.2 (8.61)

0.349

7.87 (9.37)

8.43 (10.27)

0.462

QRISK-lifetime cardiovascular risk (percentage)

60.4 (13.9)

57.8 (13.9)

0.454

62.82 (13.27)

65.42 (13.2)

0.367

  1. Continuous variables are presented as mean and standard deviation (SD) unless indicated as percentage
  2. BMI—body mass index kg/m2; CG—control group; IG—intervention group
  3. *p values under 0.05 are considered as significant and tagged with an asterisk and bold
  4. Hypertension grade 1: IG n = 40, CG n = 26
  5. Hypertension grade 2: IG n = 35, CG n = 24
  6. ††including patients who started or quit smoking during the follow-up period; Hypertension grade 1: IG n = 9, CG n = 10 Hypertension grade 2: IG n = 12, CG n = 9
  7. †††Hypertension grade 1: IG n = 39, CG n = 27
  8. Hypertension grade 2: IG n = 35, CG n = 24
  9. §Hypertension grade 1: IG n = 38, CG n = 27
  10. Hypertension grade 2: IG n = 35, CG n = 24
  11. §§Hypertension grade 1: IG n = 37, CG n = 27
  12. Hypertension grade 2: IG n = 35, CG n = 24